Related Experiment Video
Updated: May 14, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
miR-206 inhibits gastric cancer proliferation in part by repressing cyclinD2
Lin Zhang1, Xiaodong Liu, Haifeng Jin
1State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Fourth Military Medical University, Xi'an, Shaanxi Province, China.
Abstract:
In this study, we detected miR-206 expression in gastric cancer (GC) and further investigated its effects on GC cell growth in vitro and in vivo. miR-206 expression was found to be significantly decreased in 30 GC samples and GC cell lines by real time-PCR. Restoration of miR-206 reduced cell growth and colony forming ability in GC cells with G0/G1 cell cycle arrest. Further studies demonstrated that miR-206 could suppress GC cells proliferation at least partially through targeting the cyclinD2 (CCND2). Therefore, we provided evidence that miR-206 was a potential tumor suppressor and may be used as a therapeutic target for gastric cancer.
Insights
MicroRNA-206 (miR-206) is decreased in gastric cancer (GC), suppressing tumor growth by targeting cyclin D2. Restoring miR-206 offers a potential therapeutic strategy for GC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gastric cancer (GC) remains a significant global health challenge.
- The role of microRNAs (miRNAs) in GC pathogenesis is an area of active research.
- Understanding specific miRNA dysregulation, like miR-206, is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the expression levels of miR-206 in gastric cancer.
- To explore the functional impact of miR-206 on gastric cancer cell proliferation in vitro and in vivo.
- To identify potential molecular targets of miR-206 in gastric cancer.
Main Methods:
- Real-time PCR was used to quantify miR-206 expression in GC tissues and cell lines.
- In vitro assays assessed the effects of miR-206 restoration on GC cell growth and colony formation.
- Cell cycle analysis was performed to determine the mechanism of growth inhibition.
- Western blotting or similar techniques were implied for target validation (CCND2).
Main Results:
- miR-206 expression was significantly downregulated in 30 GC samples and GC cell lines.
- Restoration of miR-206 inhibited GC cell proliferation and colony formation.
- miR-206 induced G0/G1 cell cycle arrest in GC cells.
- miR-206 was found to target cyclin D2 (CCND2), contributing to proliferation suppression.
Conclusions:
- miR-206 acts as a tumor suppressor in gastric cancer.
- The downregulation of miR-206 contributes to GC progression.
- miR-206 represents a potential therapeutic target for gastric cancer treatment.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Mitogens and the Cell Cycle
Positive Regulator Molecules
MicroRNAs
MicroRNAs
